Jonah Feldman | Authors

Articles

Darovasertib/Crizotinib Shows Early Efficacy in Metastatic Uveal Melanoma

December 10, 2021

Darovasertib and crizotinib demonstrated promising efficacy and tolerable safety in patients with metastatic uveal melanoma, according to preliminary results of a phase 1/2 trial announced in a press release from IDEAYA Biosciences.